Bonnie L. Bassler - 16 Aug 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Bonnie L. Bassler
Issuer symbol
REGN
Transactions as of
16 Aug 2021
Net transactions value
-$308,785
Form type
4
Filing time
17 Aug 2021, 16:16:30 UTC
Previous filing
06 Aug 2021
Next filing
30 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $459,185 +1,219 +137% $376.69 2,110 16 Aug 2021 Direct F1
transaction REGN Common Stock Sale $767,970 -1,219 -58% $630.00 891 16 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,219 -50% $0.000000 1,219 16 Aug 2021 Common Stock 1,219 $376.69 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.